Copyright
©The Author(s) 2017.
World J Gastroenterol. Jan 21, 2017; 23(3): 516-524
Published online Jan 21, 2017. doi: 10.3748/wjg.v23.i3.516
Published online Jan 21, 2017. doi: 10.3748/wjg.v23.i3.516
Table 2 Univariable analysis of prognostic parameters for survival in Ren Ji cohort patients with gastric neuroendocrine carcinomas
Prognostic parameter | Univariable analysis | ||
HR | 95%CI | P value | |
Age (yr) | |||
< 60 | 1.0 (reference) | ||
≥ 60 | 2.718 | 0.921-8.023 | 0.070 |
Gender | |||
Male | 1.0 (reference) | ||
Female | 0.915 | 0.308-2.718 | 0.873 |
Tumor location | |||
Cardiac | 1.0 (reference) | ||
Corpus | 3.034 | 1.100-8.374 | 0.032 |
Antrum | 2.331 | 0.817-6.648 | 0.114 |
Residual stomach anastomosis | 1.401 | 0.176-11.159 | 0.750 |
Tumor size | |||
≤ 5 cm | 1.0 (reference) | ||
> 5 cm | 1.605 | 0.693-3.717 | 0.269 |
T classification | |||
T1 + T2 | 1.0 (reference) | ||
T3 + T4 | 0.760 | 0.407-1.420 | 0.390 |
Lymph node metastasis | |||
≤ 7 | 1.0 (reference) | ||
> 7 | 2.766 | 1.101-6.948 | 0.030 |
Liver metastasis | |||
Absent | 1.0 (reference) | ||
Present | 3.515 | 1.269-9.731 | 0.016 |
Adjuvant chemotherapy | |||
No-chemotherapy | 1.0 (reference) | ||
Present | 0.226 | 0.076-0.674 | 0.008 |
Chemotherapy regimen | |||
No-chemotherapy | 1.0 (reference) | ||
EP | 0.138 | 0.029-0.667 | 0.014 |
EP + PTX | 0.059 | 0.012-0.298 | 0.001 |
Other chemotherapy | 0.426 | 0.140-1.296 | 0.133 |
- Citation: Liu DJ, Fu XL, Liu W, Zheng LY, Zhang JF, Huo YM, Li J, Hua R, Liu Q, Sun YW. Clinicopathological, treatment, and prognosis study of 43 gastric neuroendocrine carcinomas. World J Gastroenterol 2017; 23(3): 516-524
- URL: https://www.wjgnet.com/1007-9327/full/v23/i3/516.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i3.516